Can lung MRI replace CT scans for detecting a serious Post-Transplant lung condition?
NCT ID NCT04080232
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether lung MRI can diagnose bronchiolitis obliterans syndrome (BOS) after allogeneic stem cell transplant as well as chest CT scans. BOS is a serious lung complication that can occur after transplant, and early diagnosis is important. Researchers compared MRI and CT scans in 16 adult patients to see if MRI could spot the same lung abnormalities. If MRI works well, it could provide a radiation-free option for monitoring these patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, lung MRI could offer a safer, radiation-free way to detect bronchiolitis obliterans syndrome earlier after stem cell transplant.
- What could go wrong
- This is a small, completed study with only 16 participants, so results may not apply to everyone. MRI may not be as accurate as CT scans for all lung details.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS OBLITERANS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Bordeaux
Bordeaux, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can airway cell clues predict a rare lung disease in children?
- New study aims to detect lung damage earlier in young transplant patients
- New inhaled therapy aims to slow lung transplant rejection
- Inhaled drug aims to save transplanted lungs from silent threat
- New xenon MRI could spot lung damage in kids after transplant
- New hope for lung scarring after transplant: belumosudil trial launches